Soluble Programmed Death-1(sPD-1) as a Diagnostic Biomarker of Interstitial Lung Disease (ILD) in Patients with Rheumatoid Arthritis
Fields of Study & Subjects
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Rheumatoid Arthritis Research and Therapies
Systemic Sclerosis and Related Diseases
Publication details
- Journal / source
- Journal of Current Medical Research and Practice
- Volume
- 11
- Issue
- 1
- Pages
- 85–94
- Publication date
- 1 January 2026
- Language
- EN